ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,309.20
-0.49%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.477
-0.05%
Brent Oil
82.075
-0.06%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Melinta Therapeutics Inc (MLNT)

  7. Melinta Therapeutics Inc (MLNT) ニュース

MLNT

Melinta Therapeutics (MLNT)

Melinta Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:MLNT
日付受信時刻ニュースソース見出しコード企業名
2020/06/2505 : 02GlobeNewswire Inc.Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of TetraphaseNASDAQ:MLNTMelinta Therapeutics Inc
2020/06/1005 : 02GlobeNewswire Inc.Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase PharmaceuticalsNASDAQ:MLNTMelinta Therapeutics Inc
2020/03/0506 : 03GlobeNewswire Inc.Melinta Therapeutics Confirms Deerfield as Successful Bidder for CompanyNASDAQ:MLNTMelinta Therapeutics Inc
2020/02/1406 : 02GlobeNewswire Inc.Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding ProceduresNASDAQ:MLNTMelinta Therapeutics Inc
2020/02/0601 : 15Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MLNTMelinta Therapeutics Inc
2020/01/0906 : 39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
2019/12/2723 : 03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
2019/12/2723 : 02GlobeNewswire Inc.Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit FacilityNASDAQ:MLNTMelinta Therapeutics Inc
2019/11/1307 : 07GlobeNewswire Inc.Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019NASDAQ:MLNTMelinta Therapeutics Inc
2019/11/1307 : 00Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNTMelinta Therapeutics Inc
2019/11/0707 : 27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
2019/10/2601 : 54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNTMelinta Therapeutics Inc
2019/10/2601 : 53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNTMelinta Therapeutics Inc
2019/10/2505 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
2019/10/2505 : 02GlobeNewswire Inc.Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Tr...NASDAQ:MLNTMelinta Therapeutics Inc
2019/10/0123 : 07PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019NASDAQ:MLNTMelinta Therapeutics Inc
2019/09/1404 : 00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNTMelinta Therapeutics Inc
2019/09/0405 : 26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
2019/09/0405 : 05GlobeNewswire Inc.Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and DirectorNASDAQ:MLNTMelinta Therapeutics Inc
2019/08/1319 : 02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MLNTMelinta Therapeutics Inc
2019/08/0920 : 41Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNTMelinta Therapeutics Inc
2019/08/0920 : 38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
2019/08/0920 : 31GlobeNewswire Inc.Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession PlanNASDAQ:MLNTMelinta Therapeutics Inc
2019/08/0920 : 30GlobeNewswire Inc.Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business UpdateNASDAQ:MLNTMelinta Therapeutics Inc
2019/08/0706 : 04GlobeNewswire Inc.Melinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results ReportingNASDAQ:MLNTMelinta Therapeutics Inc
2019/07/1705 : 51Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
2019/07/1620 : 30GlobeNewswire Inc.Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:MLNTMelinta Therapeutics Inc
2019/07/1104 : 00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MLNTMelinta Therapeutics Inc
2019/07/0306 : 23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MLNTMelinta Therapeutics Inc
2019/07/0206 : 20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MLNT

最近閲覧した銘柄

NASDAQ
GOOGL
Alphabet
AMEX
SPY
SPDR S&P 500
USOTC
ADDYY
Adidas (QX)
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
NASDAQ
TSLA
Tesla
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
SILVER
SILVER
NYSE
JPM
JP Morgan Chase
USOTC
RHHBY
Roche (QX)
NYSE
DIS
Walt Disney
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有